
Ardian has reinvested in Italian pharmaceutical company Neopharmed in a deal that sees it hold a joint majority stake with NB Renaissance.

Ardian has reinvested in Italian pharmaceutical company Neopharmed in a deal that sees it hold a joint majority stake with NB Renaissance.
Recent Comments